脏梗塞发病率,风险因素和死亡风险和脏替代疗法:一个回顾性队列研究
Hicham I Cheikh Hassan1,2, Karumathil M Murali2,3, Kelly Lambert4
1School of Medicine, Lebanese American University, Beirut, Lebanon.
Kidney360
|February 18, 2025
概括
脏病发作很少见,与普通人群相比,死亡风险没有增加. 然而,在这种情况下,患者面临替代疗法 (KRT) 的风险明显更高.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 流行病学 流行病学
背景情况:
- 脏梗塞是一种罕见的疾病,对长期结果的研究有限.
- 现有的研究主要集中在患病率和风险因素上,而不是对比的长期预测.
- 没有研究比较了脏梗塞患者与对照组的死亡率或脏替代疗法 (KRT) 等长期结果.
研究的目的:
- 为了确定脏梗塞的发病率,流行率和风险因素.
- 为了比较长期结果,特别是死亡率和KRT,脏梗塞患者和普通人群之间.
- 分析脏梗塞患者匹配队列中的死亡率和KRT调整后的风险.
主要方法:
- 从2008年到2017年,澳大利亚当地卫生区成年患者的回顾性队列研究.
- 使用逻辑回归分析发生率,流行率和风险因素的分析 (异常比率[OR],95%信心区间[95%CI]).
- 与一般人群和1:5匹配的队列进行比较,使用Cox比例危险回归 (Hazard Ratio [HR]) 对死亡率和KRT.
主要成果:
- 在140,099名患者中,0.1%发生脏梗塞,患病率为每10,000个患者年1.9.
- 风险因素包括年龄,心房动,心脏膜疾病和外周血管疾病.
- 没有观察到死亡风险增加 (调整HR 1.19,95%CI 0.89-1.61),但KRT风险显著增加 (调整HR 8.4,95%CI 3.6-19.7).
结论:
- 脏病发作是一个不常见的事件,在调整为混因素时,死亡风险没有显著增加.
- 经历脏梗塞的患者需要脏替代疗法 (KRT) 的风险要大得多.
- 这些发现凸显了脏功能和心血管健康在脏病发作后的监测的重要性.
相关概念视频
01:45Kidney Structure
68.6K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.6K
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
01:11Renal Failure: Dose Adjustments
60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
01:27Dialysis
252
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
252